HomeInsightsEPS

Bacil Pharma Ltd EPS

Bacil Pharma Ltd EPS

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

72.2 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 24, 2024

Image

Bacil Pharma Ltd

NSE: BACILPHARMA

EPS

₹ 0.65

Last updated on: Nov 22, 2024

Key Highlights

  • The Earning per Share of Bacil Pharma Ltd is ₹ 0.65 as of 22 Nov 24 .
  • The earning per share of Bacil Pharma Ltd changed from ₹ 0.04 to ₹ 0.82 over 10 quarters. This represents a CAGR of 234.74% .

Historical Earning per Share of Bacil Pharma Ltd

No data available

* All values are in

Company Fundamentals for Bacil Pharma Ltd

Market Cap

25 Cr

EPS

0.6

P/E Ratio (TTM) *

66.8

P/B Ratio (TTM) *

24.3

Day’s High *

43.44

Day’s Low

43.44

DTE *

0.1

ROE *

22.8

52 Week High

50.02

52 Week Low

4.68

ROCE *

21.0

Market Price of Bacil Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bacil Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 202443.44
21 Nov 202444.32
19 Nov 202445.22
18 Nov 202446.14
14 Nov 202447.08
13 Nov 202448.04
12 Nov 202449.02
11 Nov 202450.02
08 Nov 202449.04
07 Nov 202448.08

SWOT Analysis Of Bacil Pharma Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Bacil Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bacil Pharma Ltd

Market Value

26

Asset Value

0

149.5 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Bacil Pharma Ltd025
Sun Pharmaceuticals Industries Ltd464,31,352
Divis Laboratories Ltd691,59,265
Cipla Ltd571,20,033
Torrent Pharmaceuticals Ltd511,07,301
Mankind Pharma Ltd521,02,231

Historical Market Cap of Bacil Pharma Ltd

No data available

* All values are in crore

Historical Revenue of Bacil Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bacil Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bacil Pharma Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Bacil Pharma Ltd News Hub

News

Bacil Pharma to convene EGM

Bacil Pharma announced that an Extra Ordinary General Meeting (EGM) of the Company will be...

Read more

24 Oct 202421:01

News

Bacil Pharma to convene board meeting

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 23 October 20...

Read more

17 Oct 202412:34

News

Bacil Pharma schedules board meeting

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 15 October 20...

Read more

11 Oct 202410:31

News

Bacil Pharma announces board meeting date

Bacil Pharma will hold a meeting of the Board of Directors of the Company on 27 September ...

Read more

23 Sep 202410:09

News

Bacil Pharma to conduct AGM

Bacil Pharma announced that the Annual General Meeting (AGM) of the company will be held o...

Read more

11 Sep 202410:33

News

Bacil Pharma schedules AGM

Bacil Pharma announced that the Annual General Meeting (AGM) of the company will be held o...

Read more

11 Sep 202410:20

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Bacil Pharma Ltd

What is the EPS of Bacil Pharma Ltd stock?

The Earnings Per Share (EPS) of Bacil Pharma Ltd is 0.65. An EPS is the amount of net income attributed to each share of a common stock.

How is Bacil Pharma Ltd EPS calculated?

The EPS of Bacil Pharma Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Bacil Pharma Ltd report its EPS?

Bacil Pharma Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Bacil Pharma Ltd EPS?

Factors that influence the EPS of Bacil Pharma Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Bacil Pharma Ltd EPS growth indicate future performance?

Yes, consistent growth in Bacil Pharma Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*